Catalyst Pharmaceuticals Inc (CPRX)

Pretax margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before tax but after interest (EBT) (ttm) US$ in thousands 216,263 188,789 93,563 86,287 94,511 80,812 144,840 124,573 104,719 84,524 72,589 60,244 52,667 48,578 46,243 40,736 41,890 41,571 44,073 45,090
Revenue (ttm) US$ in thousands 491,734 460,482 434,475 411,347 398,204 348,393 302,949 256,480 214,203 191,755 170,465 153,717 140,833 133,539 126,902 120,142 119,073 118,181 119,761 118,994
Pretax margin 43.98% 41.00% 21.53% 20.98% 23.73% 23.20% 47.81% 48.57% 48.89% 44.08% 42.58% 39.19% 37.40% 36.38% 36.44% 33.91% 35.18% 35.18% 36.80% 37.89%

December 31, 2024 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $216,263K ÷ $491,734K
= 43.98%

The pretax margin of Catalyst Pharmaceuticals Inc has shown fluctuations over the past few years. It started at a strong level of 37.89% in March 2020, showing the company's ability to generate profits before taxes. The margin slightly decreased to 36.80% by June 2020 but remained relatively stable throughout the rest of 2020, hovering around 35-36%.

In the first half of 2021, there was a decline in the pretax margin to 33.91% in March, followed by a recovery to 36.44% in June. The trend continued to improve in the second half of 2021, reaching 37.40% by December. The company's profitability further increased in 2022, with the pretax margin expanding to 48.89% by December.

However, the pretax margin experienced a significant drop in the first half of 2023, falling to 23.20% in September. This downward trend continued with a slight recovery to 23.73% by December 2023. The profitability rebounded in the first half of 2024, reaching 43.98% by December 2024, showcasing a remarkable improvement.

Overall, the analysis of Catalyst Pharmaceuticals Inc's pretax margin indicates considerable variability in profitability levels over different periods, demonstrating the company's ability to adapt to changing market conditions and operational challenges.